Publication | Open Access
LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
41
Citations
0
References
2023
Year
MedicineGynecologyLba40 Phase IiiCancer TreatmentAdvanced/recurrent Endometrial CarcinomaOncologyRadiation OncologyGynecology OncologyMolecular OncologyEndocrine-related Cancer
No additional data available for this publication yet. Check back later!